We observed that, specifically, these angiotensin II (ATII)-stimulating antihypertensive users had a 45% lower dementia risk compared with users of other AHM types in the Prevention of Dementia by Intensive Vascular care (preDIVA) population [15]. The gene discussed is AGT; the disease is dementia.